High vs low omega‐3 fats
- Omega‐3 fatty acids for the primary and secondary prevention of cardiovascular disease 2020 · Cochrane Headline outcomes onlyno estimate extracted30 studies · 46604 participantsHigh
It is very uncertain whether high changes acute kidney injury compared with low blood pressure target (very low certainty).
High showed no clear difference in cognitive deterioration compared with low blood pressure target (low certainty).
It is very uncertain whether high changes all‐cause mortality compared with low blood pressure target (very low certainty).
It is very uncertain whether high changes quality of life compared with low blood pressure target (very low certainty).
It is very uncertain whether high changes acute ischaemic stroke compared with low blood pressure target (very low certainty).
High showed no clear difference in all‐cause mortality – deaths compared with low long‐chain omega‐3 fats (high certainty).
High showed no clear difference in all‐cause mortality – deaths compared with low alpha‐linolenic acid omega‐3 fats (moderate certainty).
High showed no clear difference in cardiovascular mortality – cardiovascular deaths compared with low alpha‐linolenic acid omega‐3 fats (moderate certainty).
High showed no clear difference in cardiovascular events compared with low alpha‐linolenic acid omega‐3 fats (low certainty).
High showed no clear difference in coronary heart disease mortality – CHD deaths compared with low alpha‐linolenic acid omega‐3 fats (moderate certainty).
High showed no clear difference in coronary heart disease events compared with low alpha‐linolenic acid omega‐3 fats (low certainty).
It is very uncertain whether high changes stroke compared with low alpha‐linolenic acid omega‐3 fats (very low certainty).
High probably leads to lower arrhythmias compared with low alpha‐linolenic acid omega‐3 fats (moderate certainty).
The review found no eligible studies for this question.
It is very uncertain whether high changes harms: pulmonary embolus or DVT compared with low alpha‐linolenic acid omega‐3 fats (very low certainty).
The review found no eligible studies for this question.